Electronic health records from 77 health care organizations in the US were evaluated for a risk for endocarditis among patients with opioid use disorder or cocaine use disorder on the basis of contracting COVID-19.
Your search for major depressive disorder returned 77 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Researchers measured associations between trauma and child psychiatric disorders in a birth cohort in Brazil.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
A team of investigators evaluated the prevalence of noncancer-related pain conditions among adult individuals with attention-deficit/hyperactivity disorder.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.
Investigators sought to determine if response to sympathetic nerve blocks may be predictive of response to ketamine infusion.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
How does cannabis affect COPD? To determine this, researchers assessed the risk for acute exacerbations of COPD in those who used cannabis vs those who did not.
Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.
Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
Researchers investigated whether lurasidone monotherapy would improve health-related quality of life.
Researchers investigated whether there were identifiable treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.
Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.
The risk for several major neuropsychiatric disorders in a pediatric population with atopic dermatitis is evaluated.
Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.
Looking at stress and university students during the COVID-19 pandemic.
Researchers investigated whether earlier initiation of paliperidone palmitate was associated with fewer events of treatment failure due to hospitalization, arrest, or incarceration compared with oral antipsychotics among patients with schizophrenia.
Researchers investigated whether people with behavioral variant frontotemporal dementia and schizophrenia have similar neurobiological patterns.
Investigators conducted a prospective, observational cohort study to evaluate the relationship between neuropathic pain and cognitive performance in individuals with HIV.
Pregnant women with a psychiatric disorder or receiving psychiatric medications were recruited to test the efficacy of online cognitive behavioral therapy to manage stress during the COVID-19 pandemic.
A cross-sectional family study sought to determine if parents’ transmission of anxiety is sex specific.
The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.
Outpatients were recruited at the Instituto Nacional de Psiquiatía (National Institute of Psychiatry) in Mexico and were evaluated for alcohol dependence and major depressive disorder.
To learn more about the impact of depression therapy on anxiety symptoms, researchers conducted a randomized controlled clinical trial with teenagers to compare the results of personalized depression therapy to a program that does not match their risk factors.
For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.